Cotrimoxazole prophylaxis cuts risk of death for HIV-positive patients with TB in Zambia

Aidsmap "Cotrimoxazole prophylaxis significantly reduces the risk of death in HIV-positive patients being treated for tuberculosis, according to the results of a randomised controlled trial conducted in Zambia and reported in the online edition of the British Medical Journal. The study’s findings “provide a strengthened evidence base for the UNAIDS/WHO guidelines issued in 2000” that all individuals with symptoms of HIV in Africa should receive prophylactic therapy with co-trimoxazole, say the authors."